Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal proteomic investigation of COVID-19 vaccination

6 Feb 2023

Abstract excerpt

Although the development of COVID-19 vaccines has been a remarkable success, the heterogeneous individual antibody generation and decline over time are unknown and still hard to predict. In this study, blood samples were collected from 163 participants who next received two doses of an inactivated COVID-19 vaccine (CoronaVac®) at a 28-day interval. Using TMT-based proteomics, we identified 1,715 serum and 7,342...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to interferon and immune responses
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36930526
DOI: 10.1093/procel/pwad004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal proteomic investigation of COVID-19 vaccinationPMID 36930526Read ↗

Plasma Cells, Effector T Cell, and Monocyte Single Cell Transcriptome Dynamics in T2D Patients Following SARS-CoV-2 Inactivated VaccineSemantic proximity Read ↗

Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19Semantic proximity Read ↗

Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity Read ↗

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma TherapySemantic proximity Read ↗

Humoral Immunity and Transcriptome Differences of COVID-19 Inactivated Vaccine and Protein Subunit Vaccine as Third Booster Dose in HumanSemantic proximity Read ↗

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological dataSemantic proximity Read ↗

Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunitySemantic proximity Read ↗

A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjectsSemantic proximity Read ↗

Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearanceSemantic proximity Read ↗

An Overview of the Immune Response to COVID-19 Vaccination and Strategies to Boost SARS-CoV-2 Immunity in People with Inborn Errors of ImmunitySemantic proximity Read ↗

Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesSemantic proximity Read ↗

Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVIDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.